BioSpace News Archive

New BioContinuum™ Platform provides benefits now, with a mind to continuous process of the future

Health Canada is advising consumers of the risks posed by the potential absence of required hazard symbols and health and safety labelling statements on certain Odie’s wood finishing products.

CardioMech AS announced today that it has appointed Richard Nehm as President and CEO, and Mark Novotny as Chairman of the Board of Directors, effective immediately.

GI Dynamics (ASX:GID), a medical device company that is developing EndoBarrier, held a Special Meeting on Monday, 29 October 2018 at 5:00pm United States Eastern Daylight Time (being Tuesday, 30 October 2018 at 8:00am Australian Eastern Daylight Time) and is pleased to announce that each of the resolutions put to stockholders as set forth in the Proxy Statement dated 15 October 2018 (Proxy Statement), were passed.

Five Prime Therapeutics, Inc. today announced that industry veteran David V. Smith will join the company as Executive Vice President and Chief Financial Officer (CFO), effective November 26, 2018.

Sharp, a global leader in contract packaging and clinical supply services, part of UDG Healthcare, confirmed a preferred partner agreement with innovative sterile manufacturer Berkshire Sterile Manufacturing (BSM).

Natcore Technology Inc. (TSX-V: NXT; OTCQB: NTCXF), a technology research company, has advanced an MOU that would result in a merger with a privately held firm and its subsidiaries that would become wholly owned subsidiaries of Natcore.

Stanford Children’s Health announced Friday that its board of directors has appointed Paul King as president and CEO of Lucile Packard Children’s Hospital Stanford and Stanford Children’s Health, effective in early 2019.

MedTrust Medical Transport, a MedTrust Holdings company and a premier provider of ambulance services in the Lowcountry and Pee Dee regions of South Carolina, has been named to the 2018 Inc. 5000, confirming its position among the fastest-growing companies in America.

Mitsubishi Tanabe Pharma America, Inc. (MTPA) today announced it is now accepting submissions of original visual and written artistic content from teens impacted by amyotrophic lateral sclerosis (ALS)